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Background: 18-Fluoro-2-deoxy-D-glucose positron emission tomography combined with computed tomography
(18F-FDG PET/CT) scan is useful for diagnosis of osteoarticular infections. Whether 18F-FDG PET/CT scanning may be
used for therapeutic monitoring is not clear. The objective of this study was to develop 18F-FDG PET/CT scanning
for monitoring therapeutic response to antimicrobials in experimental Staphylococcus aureus osteomyelitis.
Methods: A total of 22 rabbits were studied. In 20 animals, the right tibia was inoculated intraoperatively with
S. aureus. Two control animals were inoculated with normal saline. A needle was placed in the tibia as a foreign
body. Infection was allowed to develop for 21 days when 18F-FDG PET/CT was performed, the needle was removed,
and bone specimens were cultured to confirm infection. Antimicrobial therapy with daptomycin was initiated in all
successfully infected animals for 1, 3, or 6 weeks. Following completion of treatment, a second 18F-FDG PET/CT was
performed, animals were euthanized, and infected tibias were harvested for quantitative cultures and histology. A
positive scan was defined as 18F-FDG signal activity greater in the infected tibia than that of the contralateral
non-infected control tibia. Therapeutic response was measured by the change of 18F-FDG signal activity in the
infected tibia.
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Results: All successfully infected animals (n = 14), with microbiologically and/or histologically confirmed
osteomyelitis, had positive 18F-FDG PET/CT scans, while the two control animals had negative scans despite the
presence of the foreign body [mean maximum standardized uptake value (SUVmax) (±SD) values 2.96 (±0.80) vs. 1
(±1.10), respectively, P = 0.04]. In the 14 successfully infected animals, the mean SUVmax was significantly higher in
the infected compared to the uninfected tibia (P < 0.0001). A SUVmax of 1.4, when used as a cutoff for infection,
yielded a diagnostic accuracy of 93 %. At the end of treatment, successfully treated animals and saline controls had
a negative 18F-FDG PET/CT scan (n = 4), while animals with persistent infection despite treatment (n = 12) had a
positive 18F-FDG PET/CT scan (SUVmax 1.0–3.0) (p < 0.001). SUVmax values were significantly reduced after 42 days
of treatment from 3.15 ± 0.5 (day 7) to 1.71 ± 0.37 (day 42) (p = 0.05).
Conclusions: 18F-FDG PET/CT scan is a sensitive and specific tool in therapeutic monitoring of experimental
foreign-body osteomyelitis.
Keywords: 18F-FDG PET/CT, Experimental osteomyelitis, Staphylococcus aureus, DaptomycinIntroduction
Prosthetic joint infection (PJI) remains one of the most
dreadful complications of prosthetic joint implantation.
As clinical signs and symptoms of PJI are usually non-
specific, indolent, and vague, the diagnosis can be diffi-
cult even when accompanied by serologic, conventional
radiographic, and microbiologic diagnostic tests [1, 2].
Plain radiographs are not helpful as they lack both sensi-
tivity and specificity [3]. Computed tomography (CT)
and magnetic resonance imaging (MRI) are limited by
hardware-induced artifacts [1–3]. Functional imaging
modalities have been extensively studied and applied for
the diagnosis of PJI [4]. Yet, their diagnostic perform-
ance is not satisfactory and their routine use is not rec-
ommended [5]. Fluorine-18-fluoro-2-deoxy-D-glucose
positron emission tomography combined with computed
tomography (18F-FDG PET/CT) scan is a cutting-edge
functional imaging as it provides images with higher
resolution with concomitant anatomical information.
18F-FDG PET/CT has been reported in as a diagnostic
imaging modality tor detection of PJIs [2, 4, 6–13]; how-
ever, little is known about its potential role for monitor-
ing of response to antimicrobial therapy of osteomyelitis
and PJI.
The management of PJI often necessitates a two-stage
exchange procedure, i.e., removal of the infected pros-
thesis, prolonged courses of antimicrobial therapy, and
re-implantation after the clearance of infection [14, 15].
One unresolved issue is the optimal time for re-
implantation, because if infection reoccurs after a two-
stage exchange has been accomplished, the success rate
with a second two-stage exchange attempt may be lower
than with the first attempt [15]. Currently, there are no
diagnostic tools for monitoring the response to anti-
microbial therapy and reliably exclude persistent joint
infection, since clinical assessment, conventional im-
aging modalities, and laboratory tests may not be accur-
ate [15]. 18F-FDG PET/CT scanning has the potential toprovide objective parameters in the form of imaging and
standardized uptake value (SUV) signal strength for the
monitoring of therapeutic response in osteomyelitis.
We therefore studied 18F-FDG PET/CT scanning for
therapeutic monitoring in a rabbit model of Staphylococcus
aureus experimental foreign-body osteomyelitis. The ex-
periments were designed to assess 18F-FDG PET/CT scan
monitoring the success of antimicrobial therapy in eradi-
cating bone infection after removal of the foreign body. To
our knowledge, this is the first study of 18F-FDG PET/CT
scanning in therapeutic monitoring of systemic antibacter-
ial treatment of experimental S. aureus osteomyelitis.Methods
The study was performed in the animal facility of the Cen-
ter for Experimental Surgery of the Biomedical Research
Foundation of the Academy of Athens. The facility is reg-
istered as a “breeding” and “experimental” facility accord-
ing to the Greek Presidential Decree 160/91, on the
protection of animal used for scientific purposes. The Vet-
erinary Service of the Prefecture of Athens approved the
protocol.Study animals
A total of 22 male New Zealand white rabbits at the age
of 4 months old and a body weight between 3.0 and
3.5 kg were used in this study. The animals were pur-
chased from a registered rabbit farm (Farma Trompetas,
Megara, Attiki, Greece) and reported to be free of bac-
terial and protozoal pathogens.
Each rabbit was housed individually in a single cage in
a stainless steel rabbit cage rack (Tecniplast, Buguggiate,
Italy) in a room temperature of 21 ± 2 °C, a relative hu-
midity of 50 ± 5 %, and with a 12:12-h light-to-dark
cycle. The rabbits were fed ad libitum with a prepack-
aged certified fiber rabbit chow (12C, Pezzulo, Italy) and
had unlimited access to water via an automatic watering
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their new environment for a period of 5 days.
Study protocol
The animal model and experimental design recapitulate
the management of human PJI, including diagnosis of
infection, removal of infected prosthesis, prolonged treat-
ment with antibacterial agents, and assessment for
clearance of infection before re-implantation (Fig. 1). A
modified version of the tibial osteomyelitis model of
Norden [16, 17] was used, in which the medullary cavity of
the tibia was inoculated with methicillin-susceptible S. aur-
eus, and a 25-gauge needle was inserted into the tibia and
served as a foreign body, in both infected animals and con-
trols. Control animals were inoculated with normal saline.Fig. 1 Flow chart of our animal model of experimental foreign-body osteoInfection was allowed to develop for 21 days, and then an
18F-FDG PET/CT was performed, and blood cultures were
taken. At this time point, all the animals, infected and con-
trols, underwent a second stage surgery where the defect
area was exposed, the needle was removed, the wound was
debrided, and swab specimens and bone fragments taken
with a curette were cultured to confirm the presence of in-
fection. A bone culture yielding >104 colony-forming unit
(cfu)/ml of the initially inoculated S. aureus strain was
interpreted as established osteomyelitis.
Immediately after the second operation, antimicrobial
treatment with daptomycin (4 mg/kg every 12 h subcuta-
neous) was initiated in all successfully infected animals.
This dosage provides comparable pharmacokinetics in
rabbits and humans and has been previously studied inmyelitis
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where it achieved bone levels exceeding that of plasma
[18–20]. The rabbits were allocated to receive treat-
ment for 1, 3, or 6 weeks, in order to assess the correl-
ation of 18F-FDG uptake with the gradual resolution of
infection at different treatment time points. Following
completion of the treatment, animals underwent a sec-
ond evaluation including 18F-FDG PET/CT and blood
cultures. Then, rabbits were euthanized and infected
tibias were harvested for quantitative microbiological
cultures and histology. A bone infection was considered
as cured when at the end of treatment bone cultures
were negative for pathogens and histology was negative
for findings of infection.
Bacterial inoculum
The methicillin-susceptible S. aureus ATCC 29213 strain
(American Type Culture collection, Manassas, VA, USA)
was used for the preparation of the bacterial inoculum.
The isolate was grown overnight in Tryptic Soy Broth
(TSB) (Bioprepare, 19001, Keratea, Greece), washed three
times in ice-cold sterile buffered salt solution, and ad-
justed to a bacterial suspension equivalent to 0.5 of the
McFarland scale, measured at 600 nm (approximately
1.5 × 108 cfu/ml).
Technique of infection
The animals were anesthetized through the administration
of an intra-muscular injection of ketamine (35 mg/kg,
Imalgene 1000; Merial, Lyon, France) and xylazine (5 mg/
kg Rompun; Bayer Animal Health GmbH, Leverkusen,
Germany). The animals were intubated and connected to
a veterinary ventilator (MDS Matrx Model 2000; Hallowell
EMC, Pittsfield, MA, USA). Anesthesia was maintained
with the administration of 1 minimum alveolar concentra-
tion (MAC) isoflurane (1.7–2 %, Forenium, Abbott, Abbot
Park, IL, USA). Electrocardiography (DASH 2000 Pro, GE
Healthcare, Milwaukee, WI, USA), vital signs, and oxy-
gen saturation were monitored throughout the surgical
procedure through appropriate electrodes, a pulse ox-
imeter, and a rectal temperature probe (9-F, Mon-a-
Therm; Mallinckrodt, St Louis, MI, USA).
Surgery was performed using standard aseptic tech-
niques with one operator performing all procedures. A
2-cm incision was made in the skin 2.5 cm below the
right knee joint, which exposed the medial cortex of the
tibial metaphysis. A cortical defect was made with a 2-
mm drill bit, and 0.1 ml (approximately 1.5 × 107 cfu) of
the prepared bacterial suspension was instilled. A 25-
gauge needle was placed through the hole and served as
a foreign body, and the hub of the needle was broken
off. Finally, the drilling hole was plugged with sterile
bone wax to prevent bacterial leakage. The surgical field
was lavaged with 50 ml of sterile saline water beforewound closure in layers. The wound was cleaned using
sterile saline water, and no sealing wound coverage was
used. In control animals, a cortical defect of equal size
was drilled but 0.1 ml of sterile saline water was inocu-
lated. Further steps were similar as in the infectious ani-
mal group, up to wound closure and cleaning with
sterile saline water. Then, neomycin sulfate spray (Pulvo
47, Abott Laboratories, Hellas) was applied (manufac-
turer details), and a single dose of cefuroxime sodium
(25 mg/kg, Zinacef, GlaxoSmithKline, UK) was given IM
postoperatively. Animals returned to their cages and
given carprofen (4 mg/kg, Rimadyl, Pfizer, UK) analgesia
as needed every 12 h.
18F-FDG PET/CT imaging
18F-FDG PET/CT scans were obtained for each animal
at day 21 after the induction of osteomyelitis, as well as
at the end of treatment, just before euthanasia (Fig. 1).
The animals were not fed for at least 6 h prior to tracer
injection. Each animal was scanned 30 min after the intra-
venous administration of 74 MBq (2 mCi) of 18F-FDG in
the ear artery. Scanning was performed using a combined
18F-FDG PET/CT scanner (Siemens Biograph 6, high-
resolution PET/CT, Knoxville, TN, USA). The acquisition
time was 10 min per bed position for a total of two bed po-
sitions (20 min total acquisition time). The CT data were
used for attenuation correction, and images were recon-
structed using a standard ordered-subset expectation
maximization (OSEM) algorithm. CT images were ac-
quired with 85 mA, 130 KV, axial slice thickness of
3.0 mm, and table feed rotation of 10.0 mm per rotation.
Data were corrected for dead time, decay, and photon at-
tenuation. The image reconstruction matrix was 256 × 256.
Fusion of the PET and CT images was performed. Every
18F-FDG PET/CT scan was assessed by visual inspec-
tion by two experienced nuclear medicine physicians
blinded to the presence or not of osteomyelitis or to
the timing of the scan as far as treatment was con-
cerned. In case of disagreement, a third experienced
nuclear medicine physician assessed the images and a
consensus was achieved. An 18F-FDG PET/CT scan was
considered as positive when visual inspection showed
increased activity in the area of the inoculation com-
pared to the adjacent normal bone or to the contralat-
eral tibia. Measurements of tracer uptake were expressed
as the maximum standardized uptake value (SUVmax) in
the region of operated left tibia. Comparative measure-
ments were made for each animal (expressed as SUVmax)
in the corresponding region of the contralateral intact
right tibia.
Microbiological analysis
Tissue specimens were collected in TSB (Bioprepare,
Keratea, Greece) and homogenized using a Potter-
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82024, Germany). Swabs were diluted in 0.5 ml TSB
(Bioprepare, Keratea, Greece) and vortexed for 10 s.
Quantitative cultures from the tissue homogenizations
and the swab dilutions were performed on Columbia agar
plates supplemented with 5 % horse blood (Bioprepare,
Keratea, Greece) and incubated for 48 h in 5 % CO2 con-
ditions. Any bacterial growth that was detected was sub-
cultured and identified as the original inoculum based on
common phenotypic and susceptibility testing patterns.
Histopathology
Separate cancellous bone particles harvested on sacrifice
were fixed in neutral buffered formalin, embedded in par-
affin wax, and sectioned and stained with hematoxylin
and eosin. Tissues were examined for the presence of ab-
scesses, type of inflammatory cells, and osseous injury.
Statistical analysis
In order to determine whether the mean SUVmax
was different between the left (infected) and right
(normal) upper tibial metaphysis of the animals, the
null hypothesis was that the mean SUVmax was the
same between the two sides. Differences in SUV sig-
nals between normal and infected areas of the same
animal were analyzed paired t test. The receiver oper-
ating characteristic (ROC) analysis was used to define
the cutoff SUVmax value for infection. Differences in
therapeutic response as measured by the intensity of
SUV signal were assessed between days 7 and 42 un-
paired by t test. Comparisons of differences in pro-
portions were analyzed by Fisher’s exact test. Values
were expressed as mean ± SD, and statistical signifi-
cance was defined as P ≤ 0.05.
Results
Establishment of infection and imaging findings on day
21 after inoculation
A total of 22 animals were studied; 20 animals received
an intramedullary inoculum of S. aureus suspension, and
two control animals received sterile saline. On day 21
after inoculation, all 22 rabbits underwent an 18F-FDG
PET/CT scan followed by a second stage surgery, where
swab specimens and bone samples were taken for la-
boratory studies. Swab and bone cultures established the
presence of osteomyelitis, due to the inoculated strain of
S. aureus in 14 animals, while the inoculated pathogen
was not isolated in four animals (two controls and two
animals inoculated with S. aureus). In four animals, the
bone cultures grew pathogens other than the inoculated
S. aureus strain, notably Staphylococcus epidermidis,
probably due to contamination. All animals with failure
to establish infection (n = 2) or contamination (n = 4)
were excluded from the study resulting in a controlgroup of 2 animals and an infection group of 14 animals
(Fig. 1). In all animals, blood cultures taken on day 21
were negative for pathogens.
All 14 animals with established infection had a posi-
tive 18F-FDG PET/CT scan with SUVmax values ran-
ging from 0.9 to 4.8 (Tables 1 and 2). The two animals
in the control group had a negative 18F-FDG PET/CT
scan, despite the presence of the foreign body. The
mean SUVmax ratios were 1 (SD 1.10) and 2.96 (SD
0.80) for the control and osteomyelitis animal group,
respectively (P = 0.04) (Fig. 2). In the 14 successfully in-
fected animals, the mean SUVmax was found to be sig-
nificantly higher in the infected tibia compared to the
contralateral non-infected tibial metaphysis (t value
5.59, P value of 9 × 10−5) and the null hypothesis was
rejected.
Figure 3 shows the distribution of the SUVmax values
for the infected (left) and the normal site (right) of the
14 animals calculated from the first 18F-FDG PET/CT
scan in the series. ROC analysis showed an SUVmax
value of 1.4 as a cutoff value for infection with an accur-
acy of 93 % as well as a clear demarcation between in-
fected and normal sites.Antimicrobial treatment and follow-up studies (Table 1)
All animals with established osteomyelitis (n = 14) were
treated with daptomycin for 2 weeks (five animals),
3 weeks (five animals), or 6 weeks (four animals). All an-
imals survived until the end of the treatment period,
when a second 18F-FDG PET/CT scan was performed. A
positive 18F-FDG PET/CT scan was observed in all five
animals treated for 1 week; four of the five animals
treated for 3 weeks; and three of the four animals treated
for 6 weeks (Figs. 4 and 5). In total, at the end of the
treatment, 12 animals had a positive 18F-FDG PET/CT
scan (SUVmax 1.0–3.0) and 2 animals had a negative
18F-FDG PET/CT scan.Effect of treatment on SUVmax values
Tables 1 and 2 demonstrate the SUVmax before and
after treatment. Three weeks after the inoculation of S.
aureus and before the initiation of antimicrobial treat-
ment, the mean SUVmax value of the 14 animals that
were successfully infected was 2.6. The mean SUVmax
value was 3.66 in eight animals treated for 1 week, 2.85
in six animals treated for 3 weeks, and 2.0 in four ani-
mals treated for 6 weeks (P < 0.05) (Fig. 6). At the end of
the treatment, successfully treated animals and saline
controls had a negative 18F-FDG PET/CT scan (n = 4),
while animals with persistent infection despite treatment
(n = 12) had a positive 18F-FDG PET/CT scan (SUVmax
1.0–3.0) (p < 0.001).
Table 1 Bone infection, treatment, and 18F-FDG PET/CT scan findings in rabbit model of S. aureus osteomyelitis
Animal
number






























706 Saline No Neg No – Neg Neg – – No
693 Saline No Neg No – – – Neg Neg No
700 S. aureus No Neg No – – – – – –
701 S. aureus No Neg No – – – – – –
698 S. aureus Yes Pos (2.6) Yes 1 Pos (3.9) – – – Yes
699 S. aureus Yes Pos (4.1) Yes 1 Pos (4.8) – – – Yes
702 S. aureus Yes Pos (3.2) Yes 1 Pos (5.3) – – – Yes
703 S. aureus Yes Pos (2.6) Yes 1 Pos (2.3) – – – Yes
707 S. aureus Yes Pos (1.7) Yes 1 Pos (2.0) – – – Yes
695 S. aureus Yes Pos (1.8) Yes 3 – – Pos (3.9) – Yes
694 S. aureus Yes Pos (3.5) Yes 3 – – Pos (1.8) – Yes
692 S. aureus Yes Pos (1.4) Yes 3 Pos (1.5) Pos (1.6) Neg (0.8) – No
704 S. aureus Yes Pos (1.9) Yes 3 Pos (3.6) – Pos (3.8) – Yes
705 S. aureus Yes Pos (2.0) Yes 3 Pos (1.8) – Pos (1.9) – Yes
708 S. aureus Yes Pos (3.4) Yes 6 – – – Pos (1.6) Yes
709 S. aureus Yes Pos (2.5) Yes 6 – – – Pos (1.8) Yes
716 S. aureus Yes Pos (4.8) Yes 6 – – – Neg (0.8) No
718 S. aureus Yes Pos (0.9) Yes 6 – Pos (1.7) Pos (2.8) Pos (2.6) Yes
Tx treatment, SUVmax maximum standardized uptake value, Pos positive, Neg negative
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cultures
After the 18F-FDG PET/CT scans, animals were eutha-
nized, infected tibias were harvested, and swabs, as well
as specimens of cancellous bone, were sampled under
sterile conditions for laboratory studies. The inoculatedTable 2 SUVmax values from PET images in 14 successfully


























14 2.6 1.1 4.8 1.4 0.9 0.7
7 days of
treatment
8 3.2 1.2 5.3 1.4 1.5 0.9
14 days of
treatment
2 1.6 1.0 1.7 1.1 1.6 0.8
21 days of
treatment
6 2.5 1.0 3.9 1.4 0.8 0.8
42 days of
treatment
4 1.7 0.8 2.6 0.8 0.8 0.8
SUVmax maximum standardized uptake valuestrain of S. aureus was cultured at >104 cfu/ml or cfu/
gram of bone, from all harvested bones of the 12 animals
with a positive 18F-FDG PET/CT scan.
Histology revealed active osteomyelitis in all speci-
mens with positive cultures ≥104 cfu/ml. These findings
were interpreted as treatment failure. In contrast, the
two successfully treated animals with negative 18F-FDG
PET/CT scans and the two saline non-infected controls
had negative bone and/or swab cultures and no histo-
logical evidence of active infection.Discussion
This study found that 18F-FDG PET/CT scan is a sensi-
tive and specific tool in therapeutic monitoring of experi-
mental foreign-body osteomyelitis. The study also found
that 18F-FDG PET/CT scan accurately distinguishes be-
tween a bone with a metal implant and infection from a
bone with a metal implant but without infection. All suc-
cessfully infected animals, with microbiologically and/or
histologically confirmed foreign-body osteomyelitis, had
positive 18F-FDG PET/CT scan, while all animals without
infection had negative 18F-FDG PET/CT scan, despite the
presence of the foreign body. In all successfully infected













Fig. 2 SUVmax values at day 21 after inoculation of S. aureus (n = 14)
or normal saline (n = 2) in the tibia of the animals (**P < 0.05)
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group (P < 0.05). In addition, compared to the contralat-
eral not infected tibia, the SUVmax was significantly
higher in the infected one (P < 0.05). We also found that a
SUVmax cutoff value of 1.4 was able to differentiate
foreign-body osteomyelitis from normal bone, with an ac-
curacy of 93 %.
The rabbit model of S. aureus osteomyelitis has been
used to explore the diagnostic efficacy of 18F-FDG PET
scan. Lankier et al. showed that foreign-body-associated
infection in the rabbit tibia caused by S. epidermidis re-
sults in lower 18F-FDG uptake than pyogenic S. aureus
infections [21]. Researchers have shown by using a
rabbit model of S. aureus osteomyelitis that bone heal-
ing was associated with a temporary increase in 18F-Fig. 3 The distribution of the SUVmax values for the infected (DO)
and the normal contralateral tibia (right) of the 14 animals calculated
from the first 18F-FDG PET/CT scan in the seriesFDG uptake at 3 weeks, but it returned to normal by
6 weeks [22]. In contrast, localized osteomyelitis re-
sulted in a significantly higher, continuous uptake of
18F-FDG. Similar results have been reported in a clin-
ical study [9]. In clinical practice, 18F-FDG PET has
demonstrated promising results for diagnosis of osteo-
myelitis. Nevertheless, its role in diagnosing PJI is less
documented, as in a recent review sensitivity varied
widely from 28 to 91 % and specificity from 9 to
97 % [6]. The discrepancy between the promising re-
sults in animal models and the wide variation in 18F-
FDG PET/CT performance in the diagnosis of PJI in
clinical studies might reflect the lack of criteria to in-
terpret the 18F-FDG PET/CT scan findings suggestive
of infection.
The main objective of our study was to establish the
accuracy of 18F-FDG PET/CT scan for monitoring the
therapeutic response of bacterial osteomyelitis to anti-
microbial therapy, after removing the foreign body. We
have shown in our animal model that the SUVmax
values were significantly lower after 42 days of treat-
ment. Additionally, all 12 animals with documented per-
sistent infection after completion of antimicrobial
therapy had a positive 18F-FDG PET/CT scan, while in 2
animals where the infection had been eradicated, the
18F-FDG PET/CT scans were negative. The clinical im-
plications of these findings are obvious as in clinical
practice, the existing diagnostic modalities, such as
clinical assessment, imaging findings, or serology, can-
not accurately exclude persistent joint infection after
resection arthroplasty [14, 15]. Re-implantation with-
out previous clearance of infection might compromise
the efficacy of the two-stage exchange procedure for
the treatment of PJI. Our experimental data suggest
that in clinical practice, 18F-FDG PET/CT scan might
have a role in excluding persisting infection before
re-implantation.
Our study has several limitations. One isolate of S.
aureus was used. While other isolates of S. aureus may
have a different pro-inflammatory response, this is un-
likely. A baseline and end of therapy scan were per-
formed with no intervening scans; however, the study
design does allow for understanding different groups of
animals at different time points. A single dosage of dap-
tomycin was used. Although this study was not designed
to determine the optimal dosage and duration of dapto-
mycin for treatment of foreign-body osteomyelitis, it es-
tablishes a conceptual framework by which a larger
study may be conducted. The use of multiple experi-
mental animals, sacrificed at pre-defined time points,
and the direct documentation or exclusion of infection
by means of both bone culture and histology establishes
a correlation between therapeutic response and 18F-FDG
PET/CT imaging technology.
Fig. 5 18F-FDG PET/CT scan images of an unsuccessfully treated animal with experimental staphylococcal tibial osteomyelitis. Sagittal images of the
tibia of a rabbit demonstrating (top) increased tracer uptake (SUVmax = 3.6) with central photopenia at the area of osteomyelitis in the upper third of
the tibia extending to the adjacent soft tissues (dense arrow) after 1 week of treatment and (bottom) persistent tracer activity (SUVmax = 3.8) in the
tibia of the same rabbit (hollow arrow) after 3 weeks of treatment. The animal was euthanized immediately after the second 18F-FDG PET/CT scan, and
both bone cultures and histology showed active infection. Note: On the left are the PET images and on the right the fused PET/CT images
Fig. 4 18F-FDG PET/CT scan images of a successfully treated rabbit with experimental tibial staphylococcal osteomyelitis. Sagittal images of the
tibia of a rabbit demonstrating (top) increased tracer uptake (SUVmax = 4.8) at the area of osteomyelitis in the upper third of the tibia extending
to the adjacent soft tissues (arrow) before the initiation of treatment and (bottom) physiologic tracer activity in the tibia of the same rabbit after
6 weeks of treatment with daptomycin. The animal was euthanized immediately after the 18F-FDG PET/CT scan, and bone cultures and histology
were negative for infection. Note: On the left are the PET images and on the right the fused PET/CT images
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Fig. 6 Effect of antimicrobial treatment on the SUVmax values. Initiation of antimicrobial treatment resulted in statistically significant (p = 0.03)
reduction in the SUVmax values (left panel). The reduction was prominent at 42 days of treatment (right panel)
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In summary, 18F-FDG PET/CT imaging technology is a
sensitive and specific tool in the diagnosis of experimen-
tal foreign-body osteomyelitis and in monitoring the
therapeutic response of experimental osteomyelitis after
removal of the foreign body. These data can be used in
the development of a prospective clinical trial in the use
in the diagnosis and therapeutic monitoring of human
PJI with the use of 18F-FDG PET/CT scan.Abbreviations
18F-FDG PET/CT: fluorine-18 fluoro-2-deoxy-D-glucose positron emission
tomography combined with computed tomography; MRI: magnetic
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